✦ LIBER ✦

Synergistic cytotoxicity of human recombinant tumour necrosis factor α combined with microtubule effectors

✍ Scribed by J. Baumgart; B. Schlott; J. Suehnel; W. Vater; W. Schulze; D. Behnke

Book ID: 112578610
Publisher: Springer-Verlag
Year: 1991
Tongue: English
Weight: 581 KB
Volume: 117
Category: Article
ISSN: 1432-1335
DOI: 10.1007/bf01625431

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Synergistic cytotoxic effect of human re

Synergistic cytotoxic effect of human recombinant tumor necrosis factor alpha combined with dihydroambazone

✍ Baumgart, J.; Gase, K.; Schulze, W.; Suehnel, J.; Gutsche, W.; Behnke, D. 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 520 KB

Augmentation of recombinant interleukin-

Augmentation of recombinant interleukin-2-dependent murine macrophage-mediated tumour cytotoxicity by recombinant tumour necrosis factor-α

✍ Kos, FJ 📂 Article 📅 1989 🏛 Nature Publishing Group 🌐 English ⚖ 289 KB

Enhanced cytotoxicity and suppression of

Enhanced cytotoxicity and suppression of glucose transport rate by combined treatment of recombinant human tumour necrosis factor-α and hyperthermia on L929 cells

✍ E. Liong; S.K. Kong; K.K. Au; J.Y. Li; G.Y. Xu; Y.L. Lee; T.T. Kwok; Y.M. Choy; 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 467 KB

Analysis of recombinant human tumour nec

Analysis of recombinant human tumour necrosis factor-α-induced CD4 expression on human eosinophils

✍ M. HOSSAIN; Y. OKUBO; S. HORIE; M. SEKIGUCHI 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 538 KB

Synergistic antitumour effect of recombi

Synergistic antitumour effect of recombinant human tumour necrosis factor a with melphalan in isolated limb perfusion in the rat

✍ Dr E. R. Manusama; P. T. G. A. Nooijen; J. Stavast; N. M. C. Durante; R. L. Marq 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 510 KB

Common variable immunodeficiency treated

Common variable immunodeficiency treated with a recombinant human IgG, tumour necrosis factor-α receptor fusion protein

✍ K.J. Smith; H. Skelton 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 367 KB

Common variable immunodeficiency (CVI) is characterized by a failure in B-cell differentiation and impaired immunoglobulin secretion, but with a variable clinical presentation, including the development of sarcoidal granulomas and autoimmune diseases, as well as an increased incidence of malignancie